Subcutaneous lacosamide for seizures.
BMJ Support Palliat Care
; 2024 Feb 21.
Article
en En
| MEDLINE
| ID: mdl-38383059
ABSTRACT
The management of seizures at the end of life is vital for patient comfort and to reduce carer distress. The use of high -dose subcutaneous benzodiazepines is standard, but not always effective. We present a case where lacosamide was used subcutaneously to prevent seizure activity.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
BMJ Support Palliat Care
Año:
2024
Tipo del documento:
Article